Alkaloid profile variation across region, season, and processing

Scope and caveats

Mitragyna speciosa produces more than 40 identified alkaloids, of which mitragynine and 7-hydroxymitragynine carry most of the documented pharmacological activity. The relative concentrations of these alkaloids vary across specimens grown in different regions, harvested at different points in the season, and processed differently after harvest. This page summarises what is currently established about that variation in the peer-reviewed literature.

Vein-colour designations (red / green / white / yellow) are common commercial labels but are not standardised by a biochemical reference. The peer-reviewed record on whether vein-colour categories map cleanly onto distinct alkaloid profiles is limited; the variation documented below is primarily geographic and seasonal rather than colour-based.

Seasonal and geographic variation

Sengnon et al. (2023) reported the most systematic study to date of seasonal and geographic variation in alkaloid content of Thai-grown Mitragyna speciosa. Sampling across Thailand and across the calendar year, the authors documented substantial variation: mitragynine content in their initial sampling ranged from 0.74% w/w in October to 4.94% w/w in June, with the broader Thailand-wide dataset showing variation correlated to climate patterns and soil mineral composition — particularly calcium and magnesium levels.^[1]

The practical implication is that lots from the same grove harvested in different months can show meaningfully different mitragynine content, even before any post-harvest processing differences are introduced. Single-farm operators with consistent harvest timing can reduce this variability; the literature confirms that harvest timing matters as much as geographic origin in setting the alkaloid profile of the finished material.

Variation across the wider alkaloid set

Mitragynine and 7-hydroxymitragynine are the headline alkaloids, but the leaf produces a broader spectrum including speciogynine, speciociliatine, paynantheine, corynantheidine, and mitraphylline among others. These minor alkaloids contribute to the overall pharmacological character of the leaf even at concentrations one to two orders of magnitude below mitragynine.

Sharma et al. (2019) developed a validated UPLC-MS/MS method for parallel quantification of ten key alkaloids in raw leaf and commercial products. Their cross-product analysis demonstrated meaningful variation in the minor-alkaloid profile across commercial products labelled with the same strain or vein-colour designation, reinforcing the point that commercial labels are not a tight proxy for the underlying alkaloid profile.^[2]

What “vein colour” tells you (and what it does not)

The red / green / white / yellow vein-colour taxonomy is the most common commercial classification but it is largely a harvest-timing and processing convention rather than a biochemical category. White-vein products are typically associated with younger leaves and shorter post-harvest drying; red-vein with longer drying and fermentation. Yellow-vein is generally a processing-derived category rather than a harvest stage.

Peer-reviewed work demonstrating systematic alkaloid-profile differences across the four vein-colour categories is limited. Where comparisons exist, the within-category variation across geographic source and harvest timing tends to dwarf the between-category variation. Operators using vein-colour labels for product positioning should expect buyers with research backgrounds to ask about the underlying harvest practice, not the colour designation, when evaluating consistency.

Implications for product consistency and analytical testing

• ·Per-batch testing is the only reliable way to characterise a product's alkaloid profile. A vendor's strain or vein-colour label, by itself, does not fix the alkaloid composition. Lot-level Certificates of Analysis are the operational solution to the underlying variation.
• ·Single-farm, single-harvest sourcing reduces variability. Continuous relationships with named farms, where harvest timing and processing are consistent across lots, give tighter alkaloid profiles than blended-source supply chains.
• ·UPLC-MS/MS is the analytical reference. The Sharma et al. (2019) method, or equivalent ISO 17025-accredited UPLC-MS/MS methodology, is the operational standard for parallel quantification of the ten-plus alkaloids that matter for product characterisation.^[2]

Open questions

• ·Whether the geographic and seasonal variation documented in Thai-grown specimens generalises to Indonesian sources, particularly the West Kalimantan and Sumatran growing regions that supply most of the Western export market.
• ·A systematic peer-reviewed comparison of alkaloid profiles across red, green, white, and yellow vein-colour categories — controlling for geography and harvest timing — would clarify the biochemical basis (or lack of it) for the commercial taxonomy.
• ·The contribution of minor alkaloids (speciogynine, speciociliatine, mitraphylline, etc.) to the overall pharmacological character of the leaf, beyond mitragynine and 7-OH. Receptor characterisation of some minor alkaloids exists but is far less complete than that for the two major species.